- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer
Authors
Keywords
-
Journal
Cancers
Volume 9, Issue 12, Pages 49
Publisher
MDPI AG
Online
2017-05-09
DOI
10.3390/cancers9050049
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer
- (2017) Azam Ahmadi et al. GENE
- MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7
- (2017) Lichun Han et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Tumor B7-H3 (CD276) expression and smoking history in relation to lung adenocarcinoma prognosis
- (2017) Kentaro Inamura et al. LUNG CANCER
- MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma
- (2017) Lipin Liu et al. Molecular Cancer
- XRN2 promotes EMT and metastasis through regulating maturation of miR-10a
- (2017) H Zhang et al. ONCOGENE
- Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes
- (2017) Kentaro Inamura et al. Oncotarget
- Feedback circuitry via let-7c between lncRNA CCAT1 and c-Myc is involved in cigarette smoke extract-induced malignant transformation of HBE cells
- (2017) Lu Lu et al. Oncotarget
- MiR-93 Promotes Tumorigenesis and Metastasis of Non-Small Cell Lung Cancer Cells by Activating the PI3K/Akt Pathway via Inhibition of LKB1/PTEN/CDKN1A
- (2017) Chunmei Li et al. Journal of Cancer
- MIR155 Regulation of Ubiquilin1 and Ubiquilin2: Implications in Cellular Protection and Tumorigenesis
- (2017) Sanjay Yadav et al. NEOPLASIA
- miR-203 enhances let-7 biogenesis by targeting LIN28B to suppress tumor growth in lung cancer
- (2017) Yong Zhou et al. Scientific Reports
- Circulating Biomarkers in Non–Small-Cell Lung Cancer: Current Status and Future Challenges
- (2016) Alexios Matikas et al. Clinical Lung Cancer
- Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies
- (2016) Murali Janakiram et al. Immunotherapy
- Relationship of tumor PD-L1 expression withEGFRwild-type status and poor prognosis in lung adenocarcinoma
- (2016) Kentaro Inamura et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status
- (2016) Hyojin Kim et al. Oncotarget
- Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice
- (2016) Simona Taverna et al. Oncotarget
- Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC
- (2016) Jinpao Hou et al. Frontiers in Genetics
- MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment
- (2016) Kentaro Inamura et al. Journal of Clinical Medicine
- Differential miRNA-Expression as an Adjunctive Diagnostic Tool in Neuroendocrine Tumors of the Lung
- (2016) Melanie Demes et al. Cancers
- Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection
- (2016) Vasudha Murlidhar et al. Cancers
- Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer
- (2016) WangYu Zhu et al. PLoS One
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
- (2015) Myron G. Best et al. CANCER CELL
- miR-Test: A Blood Test for Lung Cancer Early Detection
- (2015) Francesca Montani et al. JNCI-Journal of the National Cancer Institute
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- microRNA classifiers are powerful diagnostic/prognostic tools inALK-,EGFR-, andKRAS-driven lung cancers
- (2015) Pierluigi Gasparini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1
- (2015) Ryou-u Takahashi et al. Nature Communications
- Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)*
- (2015) David M. Goldenberg et al. Oncotarget
- A Novel Serum 4-microRNA Signature for Lung Cancer Detection
- (2015) Ernest Nadal et al. Scientific Reports
- MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma—a step towards personalized therapy
- (2015) Ingrid Garajová et al. Clinical Epigenetics
- miR-Test: A Blood Test for Lung Cancer Early Detection
- (2015) Francesca Montani et al. JNCI-Journal of the National Cancer Institute
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Targeted Therapies in Non-Small Cell Lung Cancer—Beyond EGFR and ALK
- (2015) Sacha Rothschild Cancers
- The Evolution of Therapies in Non-Small Cell Lung Cancer
- (2015) Vishal Boolell et al. Cancers
- The Roles of MicroRNAs in Breast Cancer
- (2015) Ryou-u Takahashi et al. Cancers
- MicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to Therapy
- (2015) Esteban Orellana et al. Cancers
- Oncogenic MicroRNAs: Key Players in Malignant Transformation
- (2015) Tania Frixa et al. Cancers
- Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer
- (2015) Magdalena B. Wozniak et al. PLoS One
- Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
- (2014) T. Nakaoku et al. CLINICAL CANCER RESEARCH
- A MicroRNA Cluster at 14q32 Drives Aggressive Lung Adenocarcinoma
- (2014) E. Nadal et al. CLINICAL CANCER RESEARCH
- Unique microRNA-profiles inEGFR-mutated lung adenocarcinomas
- (2014) Maria Moksnes Bjaanaes et al. INTERNATIONAL JOURNAL OF CANCER
- ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: A comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features
- (2014) Yunjian Pan et al. LUNG CANCER
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined effects of asbestos and cigarette smoke on the development of lung adenocarcinoma: Different carcinogens may cause different genomic changes
- (2014) KENTARO INAMURA et al. ONCOLOGY REPORTS
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- CD74-NRG1 Fusions in Lung Adenocarcinoma
- (2014) L. Fernandez-Cuesta et al. Cancer Discovery
- miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells
- (2013) Fei Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma
- (2013) E. Nadal et al. CLINICAL CANCER RESEARCH
- B7-H3-mediated tumor immunology: Friend or foe?
- (2013) Ling Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma
- (2013) JUNKO HAMAMOTO et al. Molecular Medicine Reports
- Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
- (2013) Aria Vaishnavi et al. NATURE MEDICINE
- Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway
- (2013) H Nakanishi et al. ONCOGENE
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
- (2012) Charles M Rudin et al. NATURE GENETICS
- KIF5B-RET fusions in lung adenocarcinoma
- (2012) Takashi Kohno et al. NATURE MEDICINE
- RET, ROS1 and ALK fusions in lung cancer
- (2012) Kengo Takeuchi et al. NATURE MEDICINE
- miR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer
- (2011) E. Nishikawa et al. CANCER RESEARCH
- A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer
- (2011) Fabrizio Bianchi et al. EMBO Molecular Medicine
- Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer
- (2011) Penny Nymark et al. GENES CHROMOSOMES & CANCER
- miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity
- (2010) M-P Puisségur et al. CELL DEATH AND DIFFERENTIATION
- Accurate Classification of Non-Small Cell Lung Carcinoma Using a Novel MicroRNA-Based Approach
- (2010) J. A. Bishop et al. CLINICAL CANCER RESEARCH
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors
- (2009) H. Xu et al. CANCER RESEARCH
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
- (2009) Alice T. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma
- (2009) Danit Lebanony et al. JOURNAL OF CLINICAL ONCOLOGY
- EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology and young onset
- (2009) Kentaro Inamura et al. MODERN PATHOLOGY
- Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1
- (2009) R. Ueda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers
- (2008) Kentaro Inamura et al. Journal of Thoracic Oncology
- Lung cancer screening with low-dose computed tomography: A non-invasive diagnostic protocol for baseline lung nodules
- (2008) Giulia Veronesi et al. LUNG CANCER
- Serum MicroRNAs Are Promising Novel Biomarkers
- (2008) Shlomit Gilad et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search